Affinity Asset Advisors »

Capricor Therapeutics shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-06-30 $1.7M 175k 9.93

More positions owned by Affinity Asset Advisors

Insmed Com Par $.01 (INSM)
Verona Pharma Sponsored Ads (VRNA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Xenon Pharmaceuticals (XENE)
Madrigal Pharmaceuticals (MDGL)
Apogee Therapeutics (APGE)
Arcellx Common Stock (ACLX)
Alkermes SHS (ALKS)
Nuvalent Inc-a (NUVL)
Abivax Sa Sponsored Ads (ABVX)
Mineralys Therapeutics (MLYS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Merus N V (MRUS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Lexeo Therapeutics (LXEO)

View all positions for Affinity Asset Advisors

Top funds holding Capricor Therapeutics

BlackRock
Vanguard Group
Susquehanna International
Citadel Advisors
Geode Capital Management
Caption Management
State Street Corporation
LMR Partners
J. Goldman & Co
Morgan Stanley
Pier Capital
DG Capital Management
Ikarian Capital
Millennium Management
National Bank Of Canada /fi/

View all funds holding Capricor Therapeutics